Magnetic Resonance Imaging
Volume 27, Issue 9 , Pages 1208-1215 , November 2009

Dynamic contrast-enhanced magnetic resonance imaging parameters independent of baseline T10 values

  • Jun-Yu Guo

      Affiliations

    • Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105-3678, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 901 595 2085; fax: +1 901 595 3981.
  • ,
  • Wilburn E. Reddick

      Affiliations

    • Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105-3678, USA
  • ,
  • Mark A. Rosen

      Affiliations

    • Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • ,
  • Hee Kwon Song

      Affiliations

    • Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Received 15 August 2008 ,Revised 23 March 2009 ,Accepted 7 May 2009.

References 

  1. Buckley DL, et al. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging. 1997;7(3):461–464
  2. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging. 2002;16(4):407–422
  3. Parker GJ, et al. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging. 1997;7(3):564–574
  4. Roberts HC, et al. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol. 2000;21(5):891–899
  5. Li KL, et al. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging. 2000;12(2):347–357
  6. Zhu XP, et al. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2 contrast-enhanced dynamic MR imaging. J Magn Reson Imaging. 2000;11(6):575–585
  7. Mross K, et al. Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours. Eur J Cancer. 2005;41(9):1291–1299
  8. Thomas AL, et al. Phase I study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of PTK787/ZK 222584 administered twice daily in patients with advanced cancer. J Clin Oncol. 2005;23(18):4162–4171
  9. Harris NG, et al. MRI measurement of blood-brain barrier permeability following spontaneous reperfusion in the starch microsphere model of ischemia. Magn Reson Imaging. 2002;20(3):221–230
  10. Fritz-Hansen T, et al. Capillary transfer constant of Gd-DTPA in the myocardium at rest and during vasodilation assessed by MRI. Magn Reson Med. 1998;40(6):922–929
  11. Galbraith SM, et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed. 2002;15(2):132–142
  12. Dale BM, et al. Determining and optimizing the precision of quantitative measurements of perfusion from dynamic contrast enhanced MRI. J Magn Reson Imaging. 2003;18(5):575–584
  13. Haacke EM, et al. New algorithm for quantifying vascular changes in dynamic contrast-enhanced MRI independent of absolute T1 values. Magn Reson Med. 2007;58(3):463–472
  14. Tofts PS, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10(3):223–232
  15. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging. 1999;10(3):254–259
  16. Ogg RJ, Kingsley PB. Optimized precision of inversion-recovery T1 measurements for constrained scan time. Magn Reson Med. 2004;51(3):625–630
  17. Wang HZ, Riederer SJ, Lee JN. Optimizing the precision in T1 relaxation estimation using limited flip angles. Magn Reson Med. 1987;5(5):399–416
  18. Deoni SC, Rutt BK, Peters TM. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med. 2003;49(3):515–526
  19. Cheng HL, Wright GA. Rapid high-resolution T1 mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity. Magn Reson Med. 2006;55(3):566–574
  20. Yarnykh VL. Actual flip-angle imaging in the pulsed steady state: a method for rapid three-dimensional mapping of the transmitted radiofrequency field. Magn Reson Med. 2007;57(1):192–200
  21. McCarville MB, et al. The cause and clinical significance of central tumor photopenia on thallium scintigraphy of pediatric osteosarcoma of the extremity. AJR Am J Roentgenol. 2007;188(2):572–578
  22. Reddick WE, et al. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer. 2001;91(12):2230–2237
  23. Brix G, et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr. 1991;15(4):621–628
  24. Hoffmann U, et al. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med. 1995;33(4):506–514
  25. Larsson HB, et al. Quantitation of blood–brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med. 1990;16(1):117–131
  26. Roberts TP. Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. J Magn Reson Imaging. 1997;7(1):82–90
  27. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997;7(1):91–101
  28. Tofts PS, Kermode AG. Measurement of the blood–brain barrier permeability and leakage space using dynamic MR imaging: 1. Fundamental concepts. Magn Reson Med. 1991;17(2):357–367
  29. Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev. 1951;3(1):1–41
  30. Parker GJ, et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med. 2006;56(5):993–1000
  31. Donahue KM, et al. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med. 1994;32(1):66–76
  32. Shuter B, et al. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat. Magn Reson Imaging. 1996;14(3):243–253

PII: S0730-725X(09)00112-X

doi: 10.1016/j.mri.2009.05.015

Magnetic Resonance Imaging
Volume 27, Issue 9 , Pages 1208-1215 , November 2009